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FARMAKOLOGI TINGKAH LAKU EKSTRAK METANOL TERPIAWAI 
Mitragyna speciosa KORTH DALAM MODEL HAIWAN 
 
 
ABSTRAK 
 
Mitragyna speciosa Korth merupakan salah satu spesies tumbuhan yang digunakan oleh 
penduduk tempatan terutamanya dari Thailand dan Malaysia untuk mengubati sakit 
perut, jangkitan cacing dan juga bertindak sebagai penahan sakit dan ubat demam. 
Terdapat hanya sedikit maklumat toksiksiti, farmakologi dan kelakuan berkenaan 
dengan tumbuhan herba ini. Penyelidikan ini dijalankan untuk mengetahui peringkat 
kesan toksik secara akut ekstrak metanol terpiawai Mitragyna speciosa Korth (MS) 
dalam haiwan, untuk mengukur fungsi kognitif tikus selepas diberi MS secara akut 
melalui ujian-ujian penolakan dan untuk menerangkan kesan  MS dalam mengaruhkan 
potensi neuronal hippocampal tikus melalui teknik merekod secara ekstrasellular. Dos 
sebanyak 100, 500 and 1000 mg/kg MS diberi kepada tikus secara oral manakala 
kumpulan kawalan negatif diberi 430 mg/kg morfin, semuanya diberi satu kali sahaja. 
Lapan parameter telah dikaji iaitu; pemerhatian dalam sangkar, pengukuran berat badan, 
jumlah pengambilan makanan dan minuman, tekanan darah, berat organ secara total dan 
relatif, hematologi, analisis biokimia dan histopatologi. Pembelajaran dan ingatan diukur 
melalui ujian pengelakan pasif sehala dan pengelakan aktif dua-hala. Potensi lapangan 
pengujaan pos-sinaptik direkod secara ekstrasellular untuk mendapatkan IC50 daripada 
kepekatan MS yang berbeza (0.0001%, 0.001%, 0.005%, 0.01%, 0.05% and 0.1%). 
Potensi jangka-panjang, diukur menggunakan kepekatan IC50. Keputusan menunjukkan 
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tiada kematian dicatatkan selepas 14 hari rawatan hanya 2 kematian dicatatkan dalam 
kumpulan morfin. Tiada perubahan yang signifikan dilihat dalam kelakuan haiwan, 
jumlah pengambilan makanan dan minuman, hematologi dan berat organ. Tikus dari 
kumpulan pengangkut menunjukkan tekanan darah yang normal, manakala tikus yang 
diberi morfin menunjukkan penurunan tekanan darah secara signifikan (p < 0.05).  MS 
pula  meningkatkan tekanan darah tikus (systolic: 147.4 ±1.01, 131.64 ±4.94 and 137.8 
±4.46) selepas sejam diberikan 100, 500 and 1000 mg/kg setiap satu. Ujian biokimia 
menunjukkan peningkatan yang signifikan (p < 0.05) ALT, AST, albumin, triglycerides, 
kolesterol dan albumin pada semua peringkat dos dalam kumpulan MS dan morfin. 
Bukti nefrotoksiksiti berlaku adalah dengan peningkatan  kreatinin yang dilihat dalam 
dos 1000 mg/kg.  Ujian histologi menunjukkan pengembangan sinusoids, pemecahan sel 
hati, fatty change, nekrosis centrilobular dan peningkatan sel Kupffer dalam hati 
kumpulan haiwan yang diberikan MS dan morfin. Manakala hati tikus dari kumpulan 
pengangkut tidak menunjukkan sebarang perubahan morfologi. Keputusan histologi 
pada otak juga menunjukkan tiada perubahan yang signifikan dalam semua kumpulan 
haiwan.  Untuk keputusan ujian kelakuan haiwan, ujian menunjukkan haiwan yang 
diberi MS dan piracetam dapat belajar secara signifikan (p < 0.05)  sebagaimana 
ditunjukkan dalam ujian pengelakan pasif. Walaubagaimanapun, tiada proses ingatan 
dikesan dalam kedua-dua ujian pengelakan, aktif dan pasif.  Dalam eksperimen 
elektrofisiologi, 0.008% MS menunjukkan 50% penyekatan kepekatan (IC50). IC50 MS 
memberi tindakbalas potensi jangka-pendek dalam neuron di CA1 hippocampus tikus.  
MS juga dipercayai mengaruhkan sedikit Ca
2+
 memasuki sel pos-sinap dan 
mengaruhkan cetusan yang rendah berbanding potensi jangka-panjang. Kesimpulannya, 
dos ekstrak yang paling tinggi mengaruhkan toksik-hati yang teruk dan toksik-buah 
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pinggang yang sederhana, merencatkan ingatan dan mengaruhkan potensi jangka-pendek 
dalam hipocampus tikus. 
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BEHAVIOURAL PHARMACOLOGY OF Mitragyna speciosa KORTH 
STANDARDIZED METHANOL EXTRACT IN AN ANIMAL MODEL 
 
 
ABSTRACT 
 
Mitragyna speciosa Korth is one of the species of plant used by locals especially in 
Thailand and Malaysia in treating diarrhea, worm infestations and acts as an analgesic 
and antipyretic. There is scarcity of information in the literature regarding to toxicity, 
pharmacology and behaviour effect of this indigenous medicinal herb on. Therefore, this 
study was conducted to determine the acute toxicity level of Mitragyna speciosa Korth 
methanol extract (MS) in vivo, to evaluate cognitive functions of rats after acute 
exposure of MS using avoidance tasks and to delineate the effect of MS in inducing 
neuronal potentiation of rats’ hippocampus cells using extracellular recording. Rats were 
orally administered single dose of 100, 500 and 1000 mg/kg of MS, the positive control 
group received 430 mg/kg of morphine and negative control group received 2 mL 
vehicle (CMC) orally. Eight parameters were tested; cage side observation, body weight 
measurement, food and water consumption, blood pressure, absolute and relative organ 
weight, haematology, biochemical analysis and histopathology. Learning and memory 
were evaluated using one-way passive avoidance test and two-way active avoidance test. 
Extracellular recording of field excitatory postsynaptic potential were run to get IC50 
from various concentration of MS (0.0001%, 0.001%, 0.005%, 0.01%, 0.05% and 
0.1%). Long-term potentiation responses were evaluated using the concentration of IC50.  
No mortality was observed after 14 days of treatment; only 2 rats from morphine group 
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died. No significant changes were detected in behaviour, food and water consumption, 
haematological values and organ weights. Rats from the vehicle group showed normal 
blood pressure however, significant decreases (p < 0.05) of blood pressure were detected 
in rats from morphine group. MS significantly increased rat blood pressure (systolic: 
147.4 ±1.01, 131.64 ±4.94 and 137.8 ±4.46) after an hour of 100, 500 and 1000 mg/kg 
doses administered respectively. Biochemical studies reported statistically significant 
elevation (p < 0.05) of ALT, AST, albumin, triglycerides, cholesterol and albumin at all 
level of doses of MS and morphine. At a dose of 1000 mg/kg, elevated creatinine was 
seen, potentially a sign of nephrotoxicity. Histological examination revealed congestion 
of sinusoids, haemorrhaged hepatocytes, fatty change, centrilobular necrosis and 
increased number of Kupffer cells in the liver of all MS and morphine treated groups. 
Rat’s liver section from vehicle group however showed no morphological changes. No 
significant histological changes were seen in the brain.  On the other hand, animal 
behaviour findings have reported significant (p < 0.05) learning acquisition in the MS 
and piracetam treated group, demonstrated by the passive avoidance test. Nevertheless, 
no memory consolidation was detected, in both passive and active avoidance tests from 
rat treated with MS and morphine. In electrophysiological experiment, 0.008% of MS 
has been determined as 50% inhibitory concentration (IC50). The IC50 of MS showed 
short-term potentiation (STP) response in rat CA1 hippocampus neurons. MS is believed 
to induce less Ca
2+
 influx into postsynaptic cells and trigger lower threshold compared to 
LTP. In conclusion, the highest concentration of extract induced acute severe 
hepatotoxicity and mild nephrotoxicity, memory impairment and induced STP in the 
rat’s hippocampus.  
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CHAPTER 1 
INTRODUCTION 
 
 
World Health Organization (WHO) defines medicinal plants as plants with chemical 
characteristic that have pharmacological activities (Pensoa, 1980). Medicinal plants are 
widely used as therapeutics by locals, Malaysian traditional healers with some positive 
effects (Ong & Nordiana, 1999). Scientific ethnopharmacological studies are being 
conducted to understand the effect of medicinal plants on disease and health as well as 
the consequences of utilizing such treatment with biocompounds derived from these 
plants. 
 
Ethnopharmacological information has been used in traditional medical system 
such as Ayurveda, Unani, and traditional Chinese medicine or from herbalism folk lore 
and Shamanism (Ajibesin et al., 2008). Numerous plant species have been investigated 
namely, Salvia divinorum, Cannabis species, various members of Cactaceae, various 
members of Myristicaceae including Myristica fragrans and Knema laurina (Häke et al., 
2009) many Rubiaceae members such as Mitragyna speciosa (Shellard, 1974), and 
Psychotria species such as Tabernanthe iboga (Said et al., 1991) to study its 
phytochemical and its potential as a new therapeutic product. Knema laurina not only 
prevents neurons from inflammatory damage, but also supports early neurogenesis in 
concentrations, which are not toxic, neither in cell culture assays, nor in living brain 
tissue (Häke et al., 2009). Other speciese have been studied were Centella asiatica, 
Momordica dioica Roxb (Jain et al., 2008), Cenidium monieri and Artemisia afra 
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(Mukinda & Syce, 2007), plants that have been used to treat human ailments, namely 
Maprounnea Africana as an antidiabetic agent (Carney et al., 1999) and Taxus 
brebiflora as an antitumor drug (Samuelsson, 1992) have led researchers to gain more 
scientific proof on their effectiveness to produce  new compounds that can serve as the 
next generation of drugs to treat human disease. 
 
Previous studies reported that drugs such as psychostimulants (cocaine, 
Amphetamine, 3,4-methylenedioxy-N-methylamphetamine (MDMA) or ecstacy), 
hallucinogens (lysergic acid diethylamide (LSD), phencyclidine (PCP), and mescaline), 
opioids (morphine, heroin, codeine, methadone) and other psychoactive drugs do not 
only enhanced addiction but might disrupt the normal functions of the brain especially 
the neurochemical balance in the central nervous system (Stoelting, 1987). The central 
nervous system is controlled by a variety of biochemical functions in the body which are 
related to one another. Example of endogenous chemicals includes neurotransmitter such 
as acetylcholine, noradrenaline, dopamine, serotonin and gamma-alpha butyric acid 
(GABA) (Cooper et al., 2003).  Brain as one of the organs in the nervous system besides 
spinal cord and the peripheral nerves, controls the normal function of the body including 
all physical and physiological activities within the body for instance, movements, 
reflexes, emotions, muscle contractions, hormonal discharges and biochemical 
processes. However, brains can malfunction or experience disruption. Understanding the 
brain with its associated functions of each component is vital in order to recognise how 
brain malfunctions due to external factors such as drugs influence and internal factors 
such as disease (Harper, 1973; Eaton & Klaassen, 1996; Bloom & Brandt, 2001; Cooper 
et al., 2003). 
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When neurotoxicity occurs which changes the synthesis or density of the 
neurotransmitters or neurochemicals in the brain, it may further cause behavioral 
changes, response toward a stimulant and disturb the normal control of the brain and 
body. Since the balance of the central nervous system is the most vital part in ensuring 
the stability of the body system, any alteration towards the neurotransmitters especially 
noradrenaline, dopamine, serotonin, acetylcholine and metabolite produced may 
interfere with the behavior, thinking, movements, emotions, and motivations (McKim, 
2003). Modulation produced may cause diseases such as Parkinson, Alzheimer, 
schizophrenia, mania, stress or depression or the direct effect of drug addiction (Ellis & 
Nathan, 2001; Matthes & Kanarek, 2001; Nowakowska et al., 2001; Yamamoto et al., 
2001). 
 
Opioid drugs such as morphine may influence the balance control of the central 
nervous system (Squire, 2008). Mitragynine is also classified as an opioid, based on the 
discovery that mitragynine can act as an agonist to opioid receptors µ, κ and δ. It induces 
central and supraspinal antinociceptive effects (Matsumoto et al., 1996b; Watanabe et 
al., 1997; Yamamoto et al., 1999; Tsuchiya et al., 2002). Apparently, it has also been 
reported that the consumption or the constant usage of Mitragyna speciosa Korth may 
produce harmful effects to the consumer such as anorexia, extreme fatigue, aggressive 
behavior, excessive trembling, and mental disturbance and may lead to psychosis 
(Jansen & Prast, 1988). These symptoms are related to a disrupted central nervous 
system. The persistence usage of Mitragyna speciosa Korth may also lead to addiction 
and when it has reached the tolerance peak, the consumer needs a higher amount to gain 
pleasure. An abrupt withdrawal from consuming this drug can cause withdrawal 
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symptoms and as a matter of fact will lead to constant dependency to the plant 
(Takayama, 2004).   
 
 
1.1 Mitragyna speciosa Korth 
 
Mitragyna speciosa Korth (refer Plate 1.1) or its common name ketum belongs to the 
family Rubiaceae and also sometimes known as the Naucleae tribe from the subfamily 
Naucleoideae. Genus mitragyna can usually be found in swamps and valleys in tropical 
and subtropical Asia and Africa. Other than Southeast Asian countries such as Thailand, 
Laos, Cambodia and Malaysia (Burkill, 1966; Jansen & Prast, 1988; Hinou & Harvala, 
1988), Mitragyna speciosa may also be found in the east such as Borneo, Philippines 
and New Guinea (Burkill, 1936) in the East and West Africa as well as India (Harvala & 
Hinou, 1988) as shown in Table 1.1. 
 
Table 1.1  
Names of different species of Mitragyna based on origin  
 
Origins     Species Mitragyna 
 West Africa   Mitragyna inermis or M. Africana (Wild.) O. Kuntze 
    Mitragyna ciliate Aubrev. And Pellegr. 
    Mitragyna stipulosa (D.C.) O. Kuntze  
East Africa   Mitragyna rubrostipulate Havil. 
India and Southeast  Mitragyna hirtusa Havil 
Asia    Mitragyna tubulosa Havil. 
    Mitragyna javanica Koord. And Valeton 
    Mitragyna speciosa Korth. 
    Mitragyna parvifolia (Roxb.) Korth. 
    Mitragyna rotundifolia (Roxb.) O. Kuntze 
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Plate1.1 Picture of Mitragyna speciosa Korth plant. 
(http://www.erowid.org/plants/kratom/) 2010 
  
 
These plants from genus Mitragyna are commonly used in traditional medicine 
mostly to treat fever, diarrhea, hypertension and inflammation (Montjanel-Mouterde et 
al., 2006). The leaves, bark and roots of the plant are the parts consumed. Mitragyna 
inermis is a shrub growing plant which thrives on swampy savannas, particularly used to 
treat hepatic illnesses in Mali (Toure et al., 1996). Mitragyna ciliata is used as a cure 
against malaria (Adjétey et al., 2007).  Another species, Mitragyna stipulosa can grow 
up to 3 meters in height and grows well in the Southeast Asian region and sub-tropical 
Africa. The stem bark of this plant has been used by locals in Cameroon to alleviate 
cancer and diabetes (Tapondjou et al., 2002). Mitragyna parvifolia has been listed as a 
highly endangered tree of the Indian Thar Desert. This species is known to lessen the 
pain of wounds and swelling (Gupta et al., 2009).   
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Plate1.2 Picture of Mitragyna speciosa Korth flower. 
(http://www.sacredplant.com/id117.html) 2010 
 
 
In Malaysia, this species can be widely found in the valley area such as near the 
river in Perak and Pahang (Ridley, 1923) and Selangor (Houghton & Said, 1986). The 
common names of this species according to different countries in Southeast Asia are 
katawm, kratom and tawn in Thailand, naithum in Laos, kadam in Indonesia, khtom in 
Cambodia, ketum, kutom and biak-biak in Malaysia and beinzarbin in Burma (Burkill, 
1966). 
 
Genus Mitragyna is a large trunk tree and some species may even reach to a 
height of 100 feet. Though, usually Mitragyna speciosa only grows 50 feet and is 
recognized by its globular shape flower with 120 dark yellow florets, shiny green ovate-
acuminate leaves arranged opposite to one another and paired decusatively, having a 
fruit-like capsule with flat seeds (Shellard, 1974). 
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Mitragyna speciosa Korth is a type of tropical evergreen and non-seasonal plant. 
This species grows heavily in damp areas rich with humus and is sensitive towards 
drought and extreme coldness. During extremely cold temperature, the leaves of 
Mitragyna speciosa Korth will fall down and become infertile and consequently die 
(Macko et al., 1972). Genus Mitragyna was previously named by Korthals due to its 
stigma shape similar to a mitra bishop. However, this nomenclature has always caused 
confusion. This genus is also associated with numerous other names such as Nauclea, 
Sarcocephalus, Stephegyna and Uncaria (Shellard, 1974). 
 
Mitragyna speciosa Korth or ketum is one of the species classified under 
medicinal plants. It has long been used by locals especially in Thailand and Malaysia to 
treat various types of ailment. According to Burkill (1966), the leaves are the most 
effective part which functions as an antipyretic, antidiarrhea, analgesic, local anesthetic 
to treat worm infestations, cuts and as an antitussive. Besides that, ketum is also used in 
the diet or daily life by farmers to increase their amount of energy since it has been said 
that ketum may enhance motivation and boost the energy to complete one’s work 
without feeling exhausted (Shellard, 1974; Harvala & Hinou 1988; Jansen & Prast 
1988). 
 
Scientific researchers have proven that the active compound in ketum 
(mitragynine) is responsible to produce the therapeutic effect (Macko et al., 1972; Perry, 
1980). Mitragynine is an alkaloid which acts similarly like opioid (Matsumoto, 2006a, 
b). According to studies conducted on nociceptive activity, ileum contractility and vas 
deferens, head twitch response and writhing response, and receptor studies by 
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Matsumoto et al. (1996a, 1996b), Watanabe et al. (1997), Thongpradichote et al. (1998), 
Idid et al. (1998) and Yamamoto et al. (1999), mitragynine functions comparatively to 
morphine, however with less potency. It is widely known that morphine is a type of drug 
which has been misused and related to addiction. Since mitragynine acts at the same 
opioid receptor as morphine (µ, κ and δ receptor) and is prevented by the same 
antagonist, questions arise on how similar is mitragynine to morphine in causing 
addiction in humans.   
 
 
1.1.1 Mitragyna speciosa Korth Alkaloids 
 
From previous studies conducted, until now, 40 types of alkaloid can be found from 
various Mitragyna, 25 of them from Mitragyna speciosa Korth. The type of alkaloid 
isolated depends on two factors, time or season and location of this species (Shellard, 
1974). According to Shellard (1974), in 1907, Hooper succeeded in isolating one 
alkaloid from the leaves of Mitragyna speciosa Korth and in 1921, Field repeated the 
same procedure and named the alkaloid as mitragynine.  
 
Macko et al. (1972) reported in Mitragyna speciosa Korth the most alkaloid 
isolated comprises of three indoles and two oxindoles. Examples of indoles are 
mitragynine, paynanthine and speciogynine whereas oxindoles are mitrphylline and 
stipulatine. Other alkaloids from both types are ajmalicine, corynantheidine, mitrversine, 
rhychophylline, mitraciliatine and stipulatine. The isolation of alkaloids depends on time 
and location where the leaves were gathered. The dominant alkaloid from isolation of 
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Mitragyna speciosa Korth is mitragynine and a small quantity of mitraciliatine. During 
certain periods, corynantheidine and ajmalicine exist in the leaves of Mitragyna speciosa 
Korth. Speciophylline is also available in certain leaves collected (Shellard, 1974). 
 
Mitragynine is a dominant alkaloid from the leaves of Mitragyna speciosa Korth. 
Out of 0.5% of alkaloid isolated from the leaves, half of them belong to mitragynine 
(Takayama 2004). Mitragynine has an indole structure with a methoxy replacement at C-
9. Chemically, mitragynine is (16E, 20 β)- 16,17-didehidro-9,17-dimethoxycorynan-16-
acid carboxylic methylester; (E)-16,17-didehidro-9,17-dimetoxy-17,18-seco-20α-
yohimban-16-acid carboxylic methyl ester or simply 9-methoxy-corynantheidine. 
Molecular formula for mitragynine is C23H30N2O4 with a molecular weight of 398.5 
g/mol consisting of 69.32% of carbon, 7.59% of hydrogen, 7.03% of nitrogen and 
16.04% oxygen (Jansen & Prast, 1988). Mitragynine has a high melting point between 
102°C - 106°C and a boiling point of 239°C - 240°C. Physically, mitragynine is a white 
yellowish amorphous powder which is alcohol, chloroform, acetic acid and oily 
substance soluble. Mitragynine has a UV absorbance between the wavelength of 226 and 
292 nm (Zacharias et al., 1965; Macko et al., 1972).  
 
Since the isolation of mitragynine during the 20
th
 century by Hooper (1907) and 
Field (1921), no extensive research has been conducted to establish the effects of 
mitragynine on health and disease. Nevertheless, mitragynine studies were only limited 
to isolation and pharmacochemical studies by Shellard (1974) and Jansen & Prast 
(1988). In 1974, Zarembo et al. carried out a microbial alkaloid mitragynine 
transformation studies using a fungus, Helminthosporum sp. Two metabolites were 
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produced which were pseudoindoxyl mitragynine and pseudoindoxyl mitragynine 
hydroxyl. Since then, no further studies were conducted using these metabolites. Kechil 
et al. (1990) used a crude alkaloid extract on guinea pig to study its antinociceptive 
effect and on electrical induced ileum contraction. Similar studies were conducted by 
Matsumoto et al. (1996a) and Watanabe et al. (1997) by using mitragynine. Based on 
those studies, mitragynine effectively produce antinociceptive activity depending on 
dosage administration in hot plate and tail flick test on rats (Matsumoto et al., 1996a) 
and mitragynine prevented ileum contraction when given an electrical stimulus 
(Watanabe et al., 1997). Besides that, Watanabe et al. (1997) also proved that naloxone 
can treat or reverse the contraction inhibition by mitragynine and morphine. Between the 
two, mitragynine is ten times less potent than morphine. 
 
Matsumoto et al. (1996b) studied the role of monoaminergic system in the 
antinociceptive activity of mitragynine on the mechanical noxius stimulation. 
Matsumoto et al. (1997) further studied the effect of mitragynine to the head twitch 
response receptor 5-HT2A on rats. Mitragynine inhibits the head twitch response 
depending on the dosage administered. The result showed that α2-adrenoceptor 
stimulation and receptor inhibition 5-HT2A are involved in the head twitch inhibition 
response which induced receptor 5-HT2A towards mitragynine. A further study 
conducted proved that mitragynine acted directly on the opioid receptor instead of α2-
adrenoceptor to produce antinociceptive activity (Tohda et al., 1997). Mitragynine is 
also dominantly binded by µ and δ subtype receptor in the antinociceptive activity and 
studies in mice has shown that the selection of mitragynine for each supraspinal opioid 
receptor is different from morphine in mice (Thongpradichote et al., 1998). 7-
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hydroxymitragynine is also one of the Mitragyna speciosa Korth alkaloid; found to have 
an opiod agonist property on µ and/or κ-opiod receptor which led to the antinociceptive 
effect in mice (Matsumoto, 2003; Matsumoto, 2004). 
 
A research carried out by Idid et al. (1998) compared the action of morphine and 
paracetamol with mitragynine to produce antinociceptive and analgesic activity. The 
research found that mitragynine and morphine suppressed the writhing response induced 
by acetic acid as the antinociceptive agent. Analgesic effect is produced by all three 
drugs, mitragynine, morphine and paracetamol. Idid et al. (1998) also proposed 
mitragynine as a potential new analgesic. After almost two decades of producing 
mitragynine metabolite, Yamamoto et al. (1999) studied the effect of mitragynine 
pseudoindoxyl on electrically elicited contraction of the guinea pig’s ileum and mouse’s 
vas deferens. The result showed that potent ileum contraction inhibition effect and vas 
deferens depend on the dosage of mitragynine pseudoindoxyl. This metabolite acted on 
opioid receptor to produce potent ileum contraction inhibition through µ receptor, 
antagonized by naloxone and vas deferens contraction inhibition was via δ receptor, 
antagonized by naltrindole. This study showed that the dose for mitragynine 
pseudoindoxyl was 20-35 times lower than morphine and 100 times lower than 
mitragynine. 
 
 In the year 2002, a research conducted by Shiziko Tsuchiya found out that 
mitragynine dose dependently inhibits the 2-deoxy-D-glucose stimulated gastric acid 
secretion in the continuously perfuse stomach of anesthetized rats (Tsuchiya, 2002). A 
study conducted by Kenjiro Matsumoto in 2005, determined the effect of mitragynine on 
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neurogenic contraction in guinea pig vas deferens and on the cytosolic Ca
2+
 level in 
cultured blastoma cells.  The findings showed that mitragynine eradicated the 
electrically induced contraction of the vas deferens but failed to affect the responses to 
norepinephrine or to ATP. Mitragynine was also found to block T- and L-type Ca
2+
 
channel currents and reduce KCl
-
-induced Ca
2+
 influx in neuroblastoma cells 
(Matsumoto, 2005). Some Ca
2+
 channel blockers have been investigated to exhibit 
analgesic properties in pain tests through the blockage of neuronal Ca
2+
 channels 
(Miranda et al., 1993).  
 
 
1.1.2 Traditional Usage and its Effect 
 
In 1897, Ridley reported that the leaves and trunk of Mitragyna speciosa Korth had been 
used as treatment towards opium addiction. Moreover, a further study on the leaves of 
Mitragyna speciosa Korth in 1907 is also in accordance with the fact that the leaves of 
Mitragyna speciosa Korth and Mitragyna parvifolia can be used as a substitute of opium 
(Shellard, 1974). 
 
A long time ago, farmers in Thailand especially and north Peninsular Malaysia 
chewed and smoked on the leaves of Mitragyna speciosa Korth or mixed it with syrup to 
make a drink as a stimulant to increase the efficiency of work and to withstand extreme 
hot weather besides feeling strong and peaceful (Burkill, 1966; Shellard, 1974; Harvala 
& Hinou, 1988; Jansen & Prast, 1988). Furthermore, the leaves may also be used to treat 
fever, worm infestations and diarrhea (Burkill, 1966). Its usage has been illiglised in 
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Thailand due to its addictive properties. The government of Thailand enacted the 
Kratom 2486 Act which was enforced on 3
rd
 August 1943, stating that locals were 
disallowed to plant this tree and the existing tree needs to be cut down (Suwanlert, 1975) 
thus its use was declared illegal in Thailand since 1946 (Babu, 2008). As an alternative, 
the leaves of Mitragyna javanica were being used, however with less marked effect 
compared to Mitragyna speciosa Korth. Nowadays, the Thailand law classifies 
Mitragyna speciosa Korth similar to the groups of codeine and heroin (Suwanlert, 
1975).  
 
Besides its addictive effect, a study by Jansen & Prast (1988) on Thailand 
farmers observed that other harmful effects included dry mouth, loss of appetite, 
anorexia, weight loss, darkened skin and constipation. An excessive and chronic 
consumption of Mitragyna speciosa leaves caused extensive continuous sleep, 
aggressiveness, inability to work and pay attention, muscle pain and bone, watery eyes, 
rhinorrhea, constant trembling and psychotic behavior after prolonged use. This opposite 
effect of Mitragyna speciosa Korth somehow can be contributed by many factors. Since 
Mitragyna speciosa Korth is traditionally consumed as a tea (crude extract), it contains 
many substances or biocompounds which can give various effects (Takayama, 2004). 
The opposite effect is believed to be regulated by the exposure response. According to 
this response, the changes in effect on organism are caused at different level of doses 
after a certain exposure time (Crump et al., 1976). The pure biocompounds itself may 
behave as an agonist in some tissues while as an antagonist in others, which is called as 
selective receptor modulator (SRM). SRM are sometimes referred to as tissue selective 
drugs or mixed agonist/antagonist (Smith & O'Malley, 2004). Antagonist activity may 
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be reversible or irreversible depending on the longevity of the antagonist-receptor 
complex and on the nature of antagonist receptor binding. The majority of drug 
antagonist achieved their potency by competing with endogenous ligands or substrates at 
structurally-defined binding sites on receptors (Hopkins & Groom, 2002). This 
interaction prevent agonist-induce responses. In other words, it has the ability to bind to 
a receptor which further determine the duration of inhibition of agonist activity. Once 
bound, antagonist inhibits the function of agonist or event partial agonist (Stephenson, 
1956). Partials agonist might differ in the amplitude of the functional response that elicit 
after maximal receptor occupancy. It can act as a competitive antagonist in the presence 
of a full agonist, as it competes with the full agonist for receptor occupancy producing a 
net decrease in the receptor activation as compare to the full agonist alone resulted 
difference effect to human or other organism are exposed (Patil, 2002). At the cellular 
level, the effect can be either excitatory or inhibitory, depending on the ions that 
permeate the channels operated by the receptor. The resulting responses are either 
excitatory postsynaptic potentials (EPSPs) or inhibitory postsynaptic potentials (IPSPs), 
depending on whether they drive the cell towards a point above or below its firing 
threshold. Both EPSPs and IPSPs require Ca
2+
influx at the presynaptic cell to regulate 
neurotransmitter to bind to either glutamate receptor or GABA receptor (GABAR). For 
the EPSP, the activation of glutamate receptor by opening the receptor site will admits 
Na
+
 then further excites the postsynaptic cells. However, GABAR are normally closed, 
but when open they become selectively permeable to Cl
-
 resulted to IPSPs (Rudy, 2008). 
 
This plant is also said to have the characteristic of codeine, effective as an 
antitussive and analgesic (Harvala & Hinou, 1988; Watanabe et al., 1997). Besides its 
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potential in causing addiction, it could also be used to treat morphine addiction. This 
opposing criterion has intrigued a lot of researcher’s attention to study especially its 
pharmacological properties. Up until now, no concrete scientific evidence has been 
found to correlate the positive effect of Mitragyna speciosa Korth leaves for medical 
treatment (Houghton & Said, 1986). Perhaps, substances within Mitragyna speciosa 
Korth can be used clinically as an alternative to methadone in treating drug addicts in the 
future (Jansen & Prast, 1988). 
 
 
1.2 Toxicity 
 
Toxicology revolves around the study of adverse effects of poisons, exogenous agents 
and toxicants to the study of molecular biology. Closely related to medicine, toxicology 
comprises of collecting data in order to predict the consequences of exposure in human 
and animal population and to extrapolate hypothesis explaining the bad effects of 
chemical agents when little or no information is available. Classification of toxic agents 
may be according to their physical form (gas, dust, liquid), their chemical stability or 
reactivity (explosive, flammable, oxidizer), general chemical structure (aromatic amine, 
halogenated hydrocarbon), poison potential of being either extremely toxic to slightly 
toxic or based on the biochemical mechanism of action (alkylating agent, sulfhydryl 
inhibitor, methemoglobin producer). Chemical agents in a biological system are not 
toxic unless they have reached a proper site in the body at an extended length of time or 
concentration to produce toxic effects. Toxicity can be divided into four categories; 
acute, subacute, subchronic and chronic (Klaassen, 2001). 
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Acute exposure refers to exposure to chemicals in a single administration within 
a short period of time, less than 24 hour, with exposure routes normally through 
intraperitoneal, intravenous and subcutaneous injection, oral intubation and dermal 
application. It is the first test to be performed on a new chemical.   The LD50 (median 
lethal dose), a statistically derived single dose of a substance that can be expected to 
cause death in 50% of treated animals and other acute toxic effects are determined after 
one or more routes of administration in one or more species. Mostly, mice or rats are 
used with the exception or sometimes is being tasted in rabbits and dogs. Before dosing 
the test on animals, food is withheld during the night prior to testing. Animals that die 
within 14 days of test after a single dosage were recorded. Daily inspections of animals 
include observing for signs of intoxication, lethargy, changes in behaviour, movement 
and food consumption. The importance of this test is to provide a quantitative estimate 
of acute toxicity, to identify target organs and site of toxicity, to examine the 
reversibility of the toxic response and to give dose-ranging guidance for other studies. 
The significance of obtaining information from this test relies highly on clinical 
observations and post mortem examination rather from the LD50 value itself (Hayes, 
1982; Klaassen, 2001). 
 
Subacute toxicity tests involve repeated administration of a chemical which will 
lead to doses for subchronic studies. Normally, the protocol includes administering 3-4 
different dosages of chemicals mix in their feed. A specific number of animals were 
used for different tests. For instance, ten animals per sex and per dose were used for rats 
whereas 3 doses and 3 to 4 animals per sex for dogs. After 14 days of exposure, clinical 
chemistry and histopathology were performed. 
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Subchronic exposure lasts for different periods of time, but generally ranges 
from 1 to 3 months (Hayes, 1982). The aims of the subchronic study are to obtain no 
observed adverse effect level (NOAEL) and lowest observed adverse effect level 
(LOAEL) and to identify and characterize organs affected by toxicity after repeated 
administration. Moreover, it may provide information on cumulative effects, latency 
period for development of toxicity, reversibility of toxicity and the dose response 
relationship. The numbers obtained for NOAEL and LOAEL depend on how the 
dosages are spaced and the number of animals tested.  The endpoint for this study is 
nonlethal parameters such as biochemical, haematological, neurobehavioral as well as 
clinical measurement involving changes in body weight, food or water consumption and 
histopathological examination. This type of study is normally conducted on 2 species, 
namely the rats and dogs. The number of doses performed for 10 to 20 for rats and 4 to 6 
for dogs of each sex per dose, respectively. The first dose is a high dose which produces 
toxicity but does not cause more than 10% of fatality. The second one is a low dose 
which produces no apparent toxic effects and as for the third one, an intermediate dose. 
Observations on the animals for signs of toxicity include changes in body weight, fur 
colour or texture, respiratory or cardiovascular system, diet consumption, motor and 
behavioural abnormalities. Dead animals will be sacrificed and further test is done to the 
blood and organs. Haematological measurements such as heamatocrit, erythrocyte 
counts and common clinical measurements i.e. alanine aminotransferase (ALT), 
aminotransferase (AST), bilirubin, cholesterol and total protein are also conducted. 
Besides, urine tests on osmolarity, pH, protein, glucose, ketones and bilirubin are also 
done. 
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Unlike subchronic studies, chronic studies are usually conducted within a longer 
period of time, which may range from 6 months to 2 years. The purpose of the study is 
to determine the cumulative toxicity of chemicals and to evaluate potential carcinogenic 
effect of chemicals. The test animals are usually rats and mice with test conducted over 
their lifespan. Gross and microscopic pathological examination is conducted in both 
dead and alive animals. The highest dose for the study is according to the estimated 
maximum tolerable dose (MTD) based on body weight suppression or other indicator 
such as physiological and pharmacokinetic considerations and urinary metabolite 
profile.  
 
 
1.2.1 OECD Guidelines on Toxicology 
 
OECD guideline 407 provide information on the basic repeated dose toxicity study over 
a relatively limited period of time, normally of a 28 day period. However, a 14 day study 
period may be appropriate at certain circumstances. This guideline emphasizes more on 
neurological effects as an endpoint and thorough clinical observation of stressed 
animals. The method also includes immunological effects and reproductive organ 
toxicity (OECD 1995).  OECD guideline 420 is a guideline for fixed dose procedure in 
acute toxicity study. Under this guideline, death of an animal is not taken as an endpoint 
but is used based on observations of obvious signs of toxicity at one of a series of fixed 
dose levels (OECD 2001). In this study, both guideline 407 and 420 were adapted to get 
a clear understanding of the Mitragyna speciosa Korth standardized methanol extract 
mechanism. 
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1.3 The Central Nervous System 
 
The nervous system is an important structure, by playing its role in implementing every 
activity in the body system. This is because the nervous system is related and 
interconnected with each and every system in the body. One of the functions of the 
nervous system is to ensure homeostasis within the body system, involving body 
temperature, blood pH, electrolyte concentration in the body liquid and blood pressure 
(Hoo & Subramaniam, 1989). 
 
The structure of the nervous system can be divided into two, central nervous 
system and peripheral nervous system. Central nervous system comprises of the brain 
within the cranial cavity and spinal cord along the vertebral column. Peripheral nervous 
system connects the spinal cord to all other organs and body (Hoo & Subramaniam, 
1989). Both systems consist of a group of neurons known as ganglia in the peripheral 
nervous system and nuclei in the central nervous system. A group of axons will go 
through and between ganglion and nuclei and is called nerve in the peripheral nervous 
system and track in the central nervous system. Generally, axon is covered with myelin 
which is non-existent in the cell body. Therefore, nerve and track usually appears white 
and is defined as white matter and the cell body is grey matter (McKim, 2003). 
 
Every part of the brain plays its specific function such as; the medulla, involved 
in a wide variety of sensory and motor functions, the hypothalamus is the central control 
station for sleep or wake cycles, control of eating and drinking, control of hormone 
release, and many other critical biological functions, the pallium is involved in multiple 
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functions, including olfaction and spatial memory, the hippocampus plays a major role 
in learning and memory (Squire, 2008).  
 
 
1.3.1 The Anatomy and Physiology of Rat Hippocampus 
 
Hippocampus is a part of the brain located inside the temporal lobe. It forms a part of the 
limbic system and plays a role in memory and learning processes (Azad et al., 2003). 
Bilateral lesions of the hippocampus in animal affect specific behaviour (e.g., attention, 
arousal, and habituation), cognitive operation (e.g., learning and memory) and 
physiological reaction (e.g., skin conductance). The behavioural deficits following 
hippocampal lesioning can be reversed by administration of clinically efficacious 
antipsychotics (Schatzberg & Nemeroff, 1998). Moreover, the human brain does 
produce new nerve cells in adulthood and the newly-divided cells were found in the 
hippocampus (Izquierdo & Medina, 1997; Morris et al., 2003). However, mice that live 
in stimulating environments and use exercise wheels have more new brain cells in their 
hippocampus and perform better on learning task rather than genetically-identical mice 
that live in standard cages (Campbell, 2002). 
 
Hippocampus is grouped with other structures, the dentate gyrus, subiculum and 
entorhinal cortex, forming a part of the hippocampal formation. The rat hippocampus 
resembles a sea horse, with an appearance of two interlocking Cs, the first one with large 
backwards C and the second one with a smaller forward C. In fact, the larger C is the 
hippocampus proper or cornus ammonis (CA) whereas, the smaller one is the dentate 
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gyrus also known as fascia dentate. The hippocampus proper comprises of CA1-CA4 
regions, mainly by CA1 and CA3 in most regions and the dentate gyrus. Dentate gyrus 
are U or V shaped granule cells in rats with spherical cell bodies, arranged in four to six 
cells thick. The granule cell dendrites are connected with the granule cell layer and 
molecular layer by synaptic connections from several sources. The axons of the granule 
cells are called mossy fibers, originating from the basal portion of the cell body and 
extending into the hilus (Squire, 2008). 
 
The hippocampus pathways involve three pathways which are perforant 
pathway; mossy fiber pathway and Schaffer collateral pathway (refer to Figure 1.1).  
The perforant pathway receives the main input of the hippocampus from the entorhinal 
complex to the dentate gyrus. The second pathway, mossy fiber pathway then relates 
granule cells of dentate gyrus to the hippocampus proper of CA3. Connections are 
continued from hippocampus CA3 regions to hippocampus CA1 regions through the 
Schaeffer Collateral pathway. The information from the CA1 region travels to the 
subiculum, entering the alveus, fimbria and fornix to other areas of the brain and then to 
the entorhinal cortex (Squire, 2008). 
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Figure 1.1. Schematic representation of hippocampal connections. 
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The function of the hippocampus includes olfaction, behavioural inhibition, 
memory and spatial memory. Olfaction involvement is due to the location of 
hippocampus next to the olfactory cortex. The behavioural inhibition theory is used on 
observations on animals with hippocampal damage being hyperactive and experience 
difficulty in learning to inhibit responses previously taught. The third function relates the 
hippocampus to memory in particular describing the synthesis of episodic and semantic 
memories. The observation of Scoville and Milner in 1957, revealed that bilateral 
hippocampal removal as a treatment for epilepsy suffered by patient resulted severe 
anterograde and partial retrograde amnesia. This indicated the vital role of the 
hippocampus and temporal lobe structures in memory (Lynch, 2004). The connection of 
hippocampus to space is influenced by cognitive maps in humans and animals. Neurons 
in the rat hippocampus seem to show activity that encodes the spatial coding of the rat in 
the environment (Terry, 2006). 
 
The hippocampus is strongly related to spatial memory through the Morris water 
maze, where it depends on the animal’s ability to memorize spatial cues to locate a 
hidden underwater platform. Hippocampal and parahippocampal lesions in rats result in 
poor spatial learning, particularly if the platform is not visible to lesioned rats in the case 
of Morris water maze. However, lesioned and nonlesioned rats perform in a comparable 
manner when the platform is visible. Spatial learning tasks involved several brain areas 
with a connection between the hippocampus, subiculum and cortical areas. Nevertheless, 
impairment was less severe when damage occurs to the hippocampus only compared 
with damage to the rest of the brain areas, the perirhinal, entorhinal and 
parahippocampal cortical regions. In addition, most areas of the cortex also supports 
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various sorts of memory, namely visual sensory memory, auditory sensory memory and 
tactile memories and consolidation is required to enable the formation of long-term 
memory. This shows that not only the role of hippocampus in memory formation should 
be emphasised, but other brain parts as well (Whishaw & Kolb, 2005). 
 
In addition, working memory is also dependent on both the hippocampus and the 
prefrontal cortex. The acquisition of motor skills and habits and the memories associated 
with procedural memory relies on the striatum and cerebellum, emphasizing the 
importance of hippocampus-neocortical connections. Furthermore, the hippocampal-
prefrontal cortical connections are routed through the subiculum, which also receives 
inputs from postsubiculum and entorhinal cortex, important in processing positional, 
directional, sensory and contextual information. As a result when lesions appear to this 
area, learning deficiency may also develop. The hippocampal pathway involving CA1 
neurons projection to the perirhinal, postrhinal and entorhinal cortices also play a vital 
role in learning and memory. The impact of lesions on the degree of impairment in recall 
and retrieval of remote memory lies particularly on which brain part it affects, from that 
involving only the CA1, CA3 and dentate gyrus to the entire hippocampal complex 
(refer to Figure 1.2). For instance, a partial lesion of the hippocampus will only affect 
recent memory, without depleting remote memory, while complete hippocampal lesions 
will result in both recent and remote memory impairment, comparably (Squire, 2008). 
 
 
 
 
